Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Leukemia B-Cell Chronic

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Leukemia B-Cell Chronic:

Pubmed Logo
High Mitochondrial DNA Stability in B-Cell Chronic Lymphocytic Leukemia.
BACKGROUND: Chronic Lymphocytic Leukemia (CLL) leads to progressive...
20th November, 2009
Unidade de Xenetica, Instituto de Medicina Legal, and Departamento de PLoS One. 2009 Nov 18;4(11):e7902.
DOI Direct Link
Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death.
CML is an hematopoietic stem cell disease characterized by the t(9;22)...
20th November, 2009
INSERM UMR 895, Team 2: Cell Death Differentiation and Cancer, Nice, PLoS One. 2009 Nov 18;4(11):e7889.
DOI Direct Link
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.
ABSTRACT: Cancer precursor/progenitor cells may initiate and sustain the...
20th November, 2009
Mol Cancer. 2009 Nov 18;8(1):106.
DOI Direct Link
A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic Leukemia.
Evasion of apoptosis is a hallmark of chronic lymphocytic leukemia (CLL),...
19th November, 2009
University Children's Hospital; Department of Internal Medicine III, Ulm Cancer Res. 2009 Nov 17.
DOI Direct Link
Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
ZAP-70 is a key signaling molecule in T cells. It couples the...
13th November, 2009
3rd Department of Medicine, Hematology and Oncology, Technical University, Leukemia. 2009 Nov 12.
DOI Direct Link

View more research publications.

Press Releases About Leukemia B-Cell Chronic:

BioPortfolio Logo
Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference 24th November, 2009 Cell Therapeutics, Inc.
SEATTLE, Nov. 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 21st Annual Piper Jaffray Health Care Conference. The conference will be
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 23rd November, 2009 Amgen
THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate® (romiplostim)
DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 23rd November, 2009 DaVita Inc.
Partnerships with Minority Banks in Washington D.C., New York City, Los Angeles and Columbia, S.C. Intended to Spur Economic Growth and Revitalization WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ --
BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 23rd November, 2009 BridgePoint Medical, Inc.
MINNEAPOLIS, Nov. 23 /PRNewswire/ -- BridgePoint Medical announced today that it received European CE Mark (Conformite Europeene) for its coronary and peripheral Chronic Total Occlusion (CTO) Crossing
Reportlinker Adds Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015 20th November, 2009 Reportlinker
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Power Wheelchair Market Shares, Strategies, and Forecasts, Worldwide,

BioNews Results for Leukemia B-Cell Chronic:

RSS Logo
BioPortfolio Logo
Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia
Yahoo! Canada:  Nov 18 2009 11:54PM Matching: leukemia b cell chronic
Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCRABL cleavage and elimination of chronic myelogenous leukemia cells
Leukemia:  Nov 19 2009 2:09PM Matching: leukemia b cell chronic
Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090
Pharma Live:  Nov 19 2009 2:11AM Matching: leukemia b cell chronic
Genentech, Biogen Idec Receive Complete Response from FDA for Rituxan for CLL
Therapeutics Daily:  Nov 19 2009 12:55PM Matching: leukemia b cell chronic
Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090
Genetic Engineering News:  Nov 18 2009 2:22PM Matching: leukemia b cell chronic
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Leukemia B-Cell Chronic Patents:

USPTO Logo
US Patent No.Title
7541342 Use of PKC-activating compounds as cardioprotectants and as apoptosis-inducing anti-tumor agents
7534427 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
7510708 Disruption of the REG pathway
7256015 TALL-1 receptor molecules and uses thereof

BioPortfolio Ltd. offers e-mail and postal lists for Leukemia B-Cell Chronic scientists - we have details of around 1089 individuals working on Leukemia B-Cell Chronic .


This page has been viewed 291 times
Recent Search Terms used to find this page: leukemia b | medical advances leukemia 2008 | leukemia b-cell | Ofatumumab | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Leukemia B-Cell Chronic across BioPortfolio, or for Leukemia B-Cell Chronic Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.